Get all your news in one place.
100’s of premium titles.
One app.
Start reading

Selma Blair Opens Up About Her Ongoing Multiple Sclerosis Battle

Selma Blair

Five years ago, a well-known actress underwent hematopoietic stem cell transplantation (HSCT) as part of her battle with multiple sclerosis. In a recent interview, she candidly discussed her journey with MS, shedding light on the financial challenges faced by individuals with disabilities.

Following the HSCT procedure, the actress expressed surprise at the lengthy recovery process, emphasizing the physical toll it took on her body. Despite the challenges, she remains in remission and undergoes regular MRIs and other treatments to manage her condition.

She highlighted the financial burden of her treatments, acknowledging the privilege of being able to afford them while recognizing the struggles faced by others in similar situations. The actress emphasized the high costs associated with disability, including the expenses of necessary treatments and insurance coverage.

Opening up about her experience with MS, she shared insights into the complexities of living with a chronic illness and the adjustments required in daily life. Despite the setbacks in her acting career due to her diagnosis, she remains optimistic about the future and expressed interest in returning to work on various projects.

Reflecting on her journey, she offered advice to her past self, emphasizing the importance of patience and perseverance in the face of adversity. She remains hopeful for the future and is eager to explore new opportunities in her career.

Overall, the actress's story serves as a reminder of the challenges faced by individuals living with disabilities and the importance of raising awareness about the financial and emotional aspects of managing chronic illnesses.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.